Biomerica, Inc.
BMRA · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Revenue | $5,311 | $5,415 | $5,339 | $18,871 |
| % Growth | -1.9% | 1.4% | -71.7% | – |
| Cost of Goods Sold | $4,813 | $4,804 | $4,893 | $15,894 |
| Gross Profit | $498 | $611 | $446 | $2,977 |
| % Margin | 9.4% | 11.3% | 8.4% | 15.8% |
| R&D Expenses | $1,023 | $1,491 | $1,584 | $1,812 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,612 | $5,487 | $6,085 | $5,699 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Expenses | $5,635 | $6,978 | $7,669 | $7,511 |
| Operating Income | -$5,137 | -$6,367 | -$7,223 | -$4,534 |
| % Margin | -96.7% | -117.6% | -135.3% | -24% |
| Other Income/Exp. Net | $165 | $431 | $134 | $27 |
| Pre-Tax Income | -$4,972 | -$5,936 | -$7,089 | -$4,507 |
| Tax Expense | $1 | $42 | $51 | $24 |
| Net Income | -$4,973 | -$5,978 | -$7,140 | -$4,531 |
| % Margin | -93.6% | -110.4% | -133.7% | -24% |
| EPS | -2.16 | -0.36 | -0.5 | -0.36 |
| % Growth | -500% | 28% | -38.9% | – |
| EPS Diluted | -2.16 | -0.36 | -0.5 | -0.36 |
| Weighted Avg Shares Out | 2,297 | 16,822 | 14,154 | 12,673 |
| Weighted Avg Shares Out Dil | 2,297 | 16,822 | 14,154 | 12,673 |
| Supplemental Information | – | – | – | – |
| Interest Income | $165 | $431 | $133 | $27 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $400 | $374 | $351 | $595 |
| EBITDA | -$4,737 | -$5,993 | -$6,872 | -$3,939 |
| % Margin | -89.2% | -110.7% | -128.7% | -20.9% |